Glossary
What is…
Actionable Genetic Mutations
Actionable genetic mutations refer to DNA changes that, if detected in a patient’s tumor, would be expected (or predicted) to affect a patient’s response to treatments.
Artificial Intelligence
Artificial intelligence (AI) refers to a computer system capable of performing complex tasks that historically only a human could do, such as reasoning, making decisions, or solving problems. The goal for AI is to be able to do things such as recognize patterns, make decisions, and judge like humans.
Biomarkers and Biomarker Testing
Biomarkers are biological molecules found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Biomarker testing is a way to look for genes, proteins, and other substances (called biomarkers or tumor markers) that can provide information about cancer.
Clinical Decision Support Systems (CDSS)
A clinical decision support system (CDSS) is an application that analyzes data to assist healthcare providers in making decisions and enhancing patient care. CDSSs are computerized systems that utilize data analytics within electronic health records to analyze a patient’s medical data, which can be sent from medical devices in real-time. Subsequently, the system provides the patient’s condition to a doctor, enabling the doctor to make prescriptive decisions for the patient promptly.
Clinical Trials
Clinical trials are studies of new drugs, procedures, and other treatments for people. Doctors use clinical trials to develop new treatments for serious diseases such as cancer. They also help doctors improve the quality of life for people with cancer by testing ways to manage the side effects of cancer and its treatment.
Chemotherapy
Chemotherapy is the use of chemical agents to stop cancer cells from growing. Such category of drugs stops the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemotherapy may be given by mouth, injection, or infusion, or on the skin, depending on the type and stage of the cancer being treated.
Combination Therapies
Combination therapy is the simultaneous administration of two or more medications to treat a single disease or the administration of a combination drug, which is a dosage form that contains more than one active ingredient.
Genetic and Molecular Profiling
Molecular profiling is a laboratory technique that analyzes tissue, blood, or other body fluids to detect specific genes, proteins, or molecules indicating diseases like cancer. It can identify genetic or chromosomal changes that raise cancer risks. Often combined with biopsies, it aids in cancer diagnosis and treatment planning. Additionally, it assesses treatment effectiveness, predicts prognosis, and anticipates cancer recurrence or spread.
Types of Genetic Testing
Somatic Testing
Definition: Somatic testing looks at the DNA of cancer cells to find genetic changes (mutations) that happened in the tumor during a person’s life. These changes are not inherited.
Purpose: Urologists and oncologists use somatic testing to:
- Find specific genetic changes in cancer cells.
- Choose the best treatments.
- Understand how the cancer might behave or respond to treatments.
Germline Testing
Definition: Germline testing looks at the DNA of normal cells to find inherited genetic mutations present from birth. These mutations are in every cell of the body and can be passed to children.
Purpose: Urologists and oncologists use germline testing to:
- Find inherited genetic mutations that increase the risk of certain cancers.
- Guide decisions about cancer screening and prevention for the patient and their family.
- Help choose treatments based on inherited genetic risks.
These tests help doctors personalize cancer care by tailoring prevention, diagnosis, and treatment strategies to the individual’s genetic profile.
Genome (Genes)
The Genome is the complete set of DNA (genetic material) in an organism. In human beings almost every cell in the body contains a complete copy of the genome. The genome contains all the information needed for a person to develop and grow.
Genomic Alterations (DNA damage)
DNA damage is an alteration in the chemical structure of DNA, such as a break in a strand of DNA, a nucleobase missing from the backbone of DNA. Some of the more common genomic alterations include copy number variations, including amplification or deletion of genomic regions.
Germline
Germline refers to the sex cells (eggs and sperm) that sexually reproducing organisms use to pass on their genomes from one generation to the next (parents to offspring). Egg and sperm cells are called germ cells, in contrast to the other cells of the body, which are called somatic cells. The germline test assesses a blood sample for variants associated with hereditary cancer risk.
Hormone Therapy
Hormone Therapy is a treatment that adds, blocks, or removes hormones. In patients with prostate cancer, hormone therapy blocks or lowers the amount of testosterone in the body. This can lower the risk of prostate cancer coming back when you have it with other treatments. There are different ways of having hormone therapy such as injections, tablets, or surgery to remove testicles (orchidectomy).
Homologous Recombination Repair (HRR)
The homologous recombination repair (HRR) pathway is a process in cells where a group of proteins work together to fix damaged DNA. When this repair process doesn’t work properly, it can lead to diseases like cancer. Scientists are studying drugs that can influence this pathway to help prevent and treat cancer and other diseases.
Immunotherapy
Immunotherapy is a type of cancer treatment. It uses substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells. Immunotherapy can treat many different types of cancers. It can be used alone or in combination with chemotherapy and/or other cancer treatments.
Liquid Biopsies
A laboratory test done on a sample of blood, urine, or other body fluid to look for cancer cells from a tumor or small pieces of DNA, RNA, or other molecules released by tumor cells into a person’s body fluids. Liquid biopsy allows multiple samples to be taken over time, which may help doctors understand what kind of genetic or molecular changes are taking place in a tumor. It may also be used to help plan treatment or to find out how well treatment is working or if cancer has come back.
Multiparametric Magnetic Resonance Imaging (mpMRI)
MRI scans produce pictures from angles all around the body and shows up soft tissues very clearly. The multiparametric MRI (mpMRI) is a special type of MRI scan that produces a more detailed picture of prostate gland than a standard MRI scan does. A patient will usually have an mpMRI scan if doctors suspect prostate cancer.
PARP Inhibitors
PARP is a protein (enzyme) found in our cells and it stands for poly-ADP ribose polymerase. It helps damaged cells to repair themselves. As a cancer treatment, PARP inhibitors stop the PARP from doing its repair work in cancer cells and the cell dies.
Personalized Cancer Vaccines
Personalized vaccines in immunotherapy customize treatments to match an individual’s unique genetic and biological traits. This approach can generate a strong, tailored immune response against cancer, benefiting each patient. Additionally, these vaccines can promote long-lasting immunological memory for ongoing tumor management.
Personalized Treatment Plan
Personalized treatment plans are treatment plans that are customized according to the genetic profile of your cancer.
Precision Oncology
Precision oncology is a medical approach that tailors cancer treatment to the individual characteristics of each patient. It involves analyzing the genetic makeup of both the patient and their tumor to identify specific mutations and biomarkers driving cancer growth. By understanding these unique genetic factors, doctors can select targeted therapies that are more effective and less harmful than traditional treatments. The goal of precision oncology is to improve patient outcomes by providing personalized treatment plans based on the specific genetic profile of the cancer.
Prostate-Specific Membrane Antigen-PET (PSMA-PET) Imaging
A prostate-specific membrane antigen positron emission tomography (PSMA PET) scan is an imaging test used to detect prostate cancer throughout the body. It uses a radioactive substance that targets a protein called PSMA (prostate-specific membrane antigen), which is highly expressed by prostate cancer cells.
Prostate-Specific Antigen (PSA) Testing
The PSA test is a blood test used primarily to screen for prostate cancer. The test measures the amount of prostate-specific antigen (PSA) in your blood. PSA is a protein produced by both cancerous and noncancerous tissue in the prostate.
Radioligand Therapy
Radioligand therapy is a type of cancer treatment that uses radioactive substances to target and kill cancer cells. For example, PSMA is a protein that is found on the surface of prostate cancer cells. Lu-PSMA binds to PSMA and delivers a radioactive payload to the cancer cell, killing it.
Targeted Cancer Therapies
Targeted therapy is a type of cancer treatment that employs drugs designed to target proteins specifically expressed on the surface or within cancer cells that control how cancer cells grow, divide, and spread without affecting normal cells.
Variant of Uncertain Significance (VUS)
VUS stands for “Variant of Uncertain Significance.” It refers to a change in a gene’s DNA sequence that scientists and doctors don’t yet understand. They don’t know if this change is harmless, could cause a disease, or has some other effect. VUS is often found during genetic testing, and more research is needed to understand its impact.